Home    Back

Target Gene/Pathway💬 Info on mouse-over

e.g. Sirolimus, Adalimumab, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

96 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
 [1] RARA 💬 D02754 💬 Acitretin [1] 37 💬
2 Adipocytokine signaling pathway 💬
 [3] RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
3 Adipocytokine signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
4 Adipocytokine signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
5 Adipocytokine signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
6 African trypanosomiasis 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
7 African trypanosomiasis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
8 African trypanosomiasis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
9 African trypanosomiasis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
11 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
12 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
13 Allograft rejection 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
14 Allograft rejection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
15 Allograft rejection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
16 Allograft rejection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
17 Alzheimer disease 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
18 Alzheimer disease 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
19 Alzheimer disease 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
20 Amoebiasis 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
21 Amoebiasis 💬
 [2] IL1R1, IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
22 Amoebiasis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
23 Amoebiasis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
24 Amoebiasis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
25 Amyotrophic lateral sclerosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
26 Amyotrophic lateral sclerosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
27 Amyotrophic lateral sclerosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
28 Antifolate resistance 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
29 Antifolate resistance 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
30 Antifolate resistance 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
31 Antigen processing and presentation 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
32 Antigen processing and presentation 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
33 Antigen processing and presentation 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
34 Apoptosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
35 Apoptosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
36 Apoptosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
37 Asthma 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
38 Asthma 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
39 Asthma 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
40 Bile secretion 💬
 [1] RXRA 💬 D02754 💬 Acitretin [1] 37 💬
41 C-type lectin receptor signaling pathway 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
42 C-type lectin receptor signaling pathway 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
43 C-type lectin receptor signaling pathway 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
44 C-type lectin receptor signaling pathway 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
45 C-type lectin receptor signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
46 C-type lectin receptor signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
47 C-type lectin receptor signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
48 Cell adhesion molecules 💬
 [1] CD58 💬 D02800 💬 Alefacept [6] 37, 60, 65, 164, 284, 285 💬
49 Cell adhesion molecules 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
50 Chagas disease 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
51 Chagas disease 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
52 Chagas disease 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
53 Chagas disease 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
54 Coronavirus disease - COVID-19 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
55 Coronavirus disease - COVID-19 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
56 Coronavirus disease - COVID-19 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
57 Coronavirus disease - COVID-19 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
58 Cytokine-cytokine receptor interaction 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
59 Cytokine-cytokine receptor interaction 💬
 [1] IL17A 💬 D10071 💬 Ixekizumab [5] 36, 37, 162, 269, 271 💬
60 Cytokine-cytokine receptor interaction 💬
 [1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
61 Cytokine-cytokine receptor interaction 💬
 [1] IL17RA 💬 D10061 💬 Brodalumab [2] 37, 51 💬
62 Cytokine-cytokine receptor interaction 💬
 [2] IL1R1, IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
63 Cytokine-cytokine receptor interaction 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
64 Cytokine-cytokine receptor interaction 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
65 Cytokine-cytokine receptor interaction 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
66 Cytokine-cytokine receptor interaction 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
67 Cytokine-cytokine receptor interaction 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
68 Cytokine-cytokine receptor interaction 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
69 Dilated cardiomyopathy 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
70 Dilated cardiomyopathy 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
71 Dilated cardiomyopathy 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
72 Drug metabolism - other enzymes 💬
 [1] HPRT1 💬 D06109 💬 Tioguanine [2] 13, 37 💬
73 Drug metabolism - other enzymes 💬
 [1] HPRT1 💬 D08603 💬 Tioguanine [2] 13, 37 💬
74 Endocrine and other factor-regulated calcium reabsorption 💬
 [1] VDR 💬 D00129 💬 Calcitriol [8] 37, 46, 49, 66, 96, 158, 235, 326 💬
75 Epstein-Barr virus infection 💬
 [1] CD58 💬 D02800 💬 Alefacept [6] 37, 60, 65, 164, 284, 285 💬
76 Epstein-Barr virus infection 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
77 Epstein-Barr virus infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
78 Epstein-Barr virus infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
79 Epstein-Barr virus infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
80 Estrogen signaling pathway 💬
 [1] RARA 💬 D02754 💬 Acitretin [1] 37 💬
81 Fc epsilon RI signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
82 Fc epsilon RI signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
83 Fc epsilon RI signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
84 Fluid shear stress and atherosclerosis 💬
 [2] IL1R1, IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
85 Fluid shear stress and atherosclerosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
86 Fluid shear stress and atherosclerosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
87 Fluid shear stress and atherosclerosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
88 Gastric cancer 💬
 [4] RARB, RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
89 Graft-versus-host disease 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
90 Graft-versus-host disease 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
91 Graft-versus-host disease 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
92 Hematopoietic cell lineage 💬
 [2] IL1R1, IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
93 Hematopoietic cell lineage 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
94 Hematopoietic cell lineage 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
95 Hematopoietic cell lineage 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
96 Hepatitis B 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
97 Hepatitis B 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
98 Hepatitis B 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
99 Hepatitis C 💬
 [1] RXRA 💬 D02754 💬 Acitretin [1] 37 💬
100 Hepatitis C 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
101 Hepatitis C 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
102 Hepatitis C 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
103 Herpes simplex virus 1 infection 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
104 Herpes simplex virus 1 infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
105 Herpes simplex virus 1 infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
106 Herpes simplex virus 1 infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
107 Human cytomegalovirus infection 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
108 Human cytomegalovirus infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
109 Human cytomegalovirus infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
110 Human cytomegalovirus infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
111 Human immunodeficiency virus 1 infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
112 Human immunodeficiency virus 1 infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
113 Human immunodeficiency virus 1 infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
114 Human papillomavirus infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
115 Human papillomavirus infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
116 Human papillomavirus infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
117 Human T-cell leukemia virus 1 infection 💬
 [2] IL1R1, IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
118 Human T-cell leukemia virus 1 infection 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
119 Human T-cell leukemia virus 1 infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
120 Human T-cell leukemia virus 1 infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
121 Human T-cell leukemia virus 1 infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
122 Hypertrophic cardiomyopathy 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
123 Hypertrophic cardiomyopathy 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
124 Hypertrophic cardiomyopathy 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
125 IL-17 signaling pathway 💬
 [1] IL17A 💬 D10071 💬 Ixekizumab [5] 36, 37, 162, 269, 271 💬
126 IL-17 signaling pathway 💬
 [1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
127 IL-17 signaling pathway 💬
 [1] IL17RA 💬 D10061 💬 Brodalumab [2] 37, 51 💬
128 IL-17 signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
129 IL-17 signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
130 IL-17 signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
131 Inflammatory bowel disease 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
132 Inflammatory bowel disease 💬
 [1] IL17A 💬 D10071 💬 Ixekizumab [5] 36, 37, 162, 269, 271 💬
133 Inflammatory bowel disease 💬
 [1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
134 Inflammatory bowel disease 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
135 Inflammatory bowel disease 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
136 Inflammatory bowel disease 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
137 Inflammatory bowel disease 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
138 Inflammatory bowel disease 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
139 Inflammatory bowel disease 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
140 Inflammatory mediator regulation of TRP channels 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
141 Influenza A 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
142 Influenza A 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
143 Influenza A 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
144 Influenza A 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
145 Insulin resistance 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
146 Insulin resistance 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
147 Insulin resistance 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
148 JAK-STAT signaling pathway 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
149 JAK-STAT signaling pathway 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
150 JAK-STAT signaling pathway 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
151 JAK-STAT signaling pathway 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
152 Legionellosis 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
153 Legionellosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
154 Legionellosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
155 Legionellosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
156 Leishmaniasis 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
157 Leishmaniasis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
158 Leishmaniasis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
159 Leishmaniasis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
160 Leukocyte transendothelial migration 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
161 Malaria 💬
 [1] IL12A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
162 Malaria 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
163 Malaria 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
164 Malaria 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
165 Malaria 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
166 MAPK signaling pathway 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
167 MAPK signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
168 MAPK signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
169 MAPK signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
170 Measles 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
171 Metabolic pathways 💬
 [1] HPRT1 💬 D06109 💬 Tioguanine [2] 13, 37 💬
172 Metabolic pathways 💬
 [1] HPRT1 💬 D08603 💬 Tioguanine [2] 13, 37 💬
173 Mineral absorption 💬
 [1] VDR 💬 D00129 💬 Calcitriol [8] 37, 46, 49, 66, 96, 158, 235, 326 💬
174 mTOR signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
175 mTOR signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
176 mTOR signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
177 Natural killer cell mediated cytotoxicity 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
178 Natural killer cell mediated cytotoxicity 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
179 Natural killer cell mediated cytotoxicity 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
180 Natural killer cell mediated cytotoxicity 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
181 Necroptosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
182 Necroptosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
183 Necroptosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
184 Neutrophil extracellular trap formation 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
185 NF-kappa B signaling pathway 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
186 NF-kappa B signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
187 NF-kappa B signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
188 NF-kappa B signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
189 NOD-like receptor signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
190 NOD-like receptor signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
191 NOD-like receptor signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
192 Non-alcoholic fatty liver disease 💬
 [1] RXRA 💬 D02754 💬 Acitretin [1] 37 💬
193 Non-alcoholic fatty liver disease 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
194 Non-alcoholic fatty liver disease 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
195 Non-alcoholic fatty liver disease 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
196 Non-small cell lung cancer 💬
 [4] RARB, RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
197 Osteoclast differentiation 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
198 Osteoclast differentiation 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
199 Osteoclast differentiation 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
200 Osteoclast differentiation 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
201 Parathyroid hormone synthesis, secretion and action 💬
 [3] RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
202 Parathyroid hormone synthesis, secretion and action 💬
 [1] VDR 💬 D00129 💬 Calcitriol [8] 37, 46, 49, 66, 96, 158, 235, 326 💬
203 Pathogenic Escherichia coli infection 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
204 Pathogenic Escherichia coli infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
205 Pathogenic Escherichia coli infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
206 Pathogenic Escherichia coli infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
207 Pathways in cancer 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
208 Pathways in cancer 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
209 Pathways in cancer 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
210 Pathways in cancer 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
211 Pathways in cancer 💬
 [5] RARA, RARB, RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
212 Pathways of neurodegeneration - multiple diseases 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
213 Pathways of neurodegeneration - multiple diseases 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
214 Pathways of neurodegeneration - multiple diseases 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
215 Pertussis 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
216 Pertussis 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
217 Pertussis 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
218 Pertussis 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
219 Pertussis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
220 Pertussis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
221 Pertussis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
222 PI3K-Akt signaling pathway 💬
 [1] RXRA 💬 D02754 💬 Acitretin [1] 37 💬
223 PPAR signaling pathway 💬
 [3] RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
224 Prion disease 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
225 Prion disease 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
226 Prion disease 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
227 Prostate cancer 💬
 [1] IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
228 Proteoglycans in cancer 💬
 [1] IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
229 Proteoglycans in cancer 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
230 Proteoglycans in cancer 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
231 Proteoglycans in cancer 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
232 Purine metabolism 💬
 [1] HPRT1 💬 D06109 💬 Tioguanine [2] 13, 37 💬
233 Purine metabolism 💬
 [1] HPRT1 💬 D08603 💬 Tioguanine [2] 13, 37 💬
234 Rap1 signaling pathway 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
235 Regulation of actin cytoskeleton 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
236 Rheumatoid arthritis 💬
 [1] IL17A 💬 D10071 💬 Ixekizumab [5] 36, 37, 162, 269, 271 💬
237 Rheumatoid arthritis 💬
 [1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
238 Rheumatoid arthritis 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
239 Rheumatoid arthritis 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
240 Rheumatoid arthritis 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
241 Rheumatoid arthritis 💬
 [1] IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
242 Rheumatoid arthritis 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
243 Rheumatoid arthritis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
244 Rheumatoid arthritis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
245 Rheumatoid arthritis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
246 RIG-I-like receptor signaling pathway 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
247 RIG-I-like receptor signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
248 RIG-I-like receptor signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
249 RIG-I-like receptor signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
250 Salmonella infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
251 Salmonella infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
252 Salmonella infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
253 Shigellosis 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
254 Shigellosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
255 Shigellosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
256 Shigellosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
257 Small cell lung cancer 💬
 [4] RARB, RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
258 Sphingolipid signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
259 Sphingolipid signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
260 Sphingolipid signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
261 Staphylococcus aureus infection 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
262 Systemic lupus erythematosus 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
263 Systemic lupus erythematosus 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
264 Systemic lupus erythematosus 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
265 T cell receptor signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
266 T cell receptor signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
267 T cell receptor signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
268 TGF-beta signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
269 TGF-beta signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
270 TGF-beta signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
271 Th1 and Th2 cell differentiation 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
272 Th17 cell differentiation 💬
 [1] IL17A 💬 D10071 💬 Ixekizumab [5] 36, 37, 162, 269, 271 💬
273 Th17 cell differentiation 💬
 [1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
274 Th17 cell differentiation 💬
 [1] IL1R1 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
275 Th17 cell differentiation 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
276 Th17 cell differentiation 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
277 Th17 cell differentiation 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
278 Th17 cell differentiation 💬
 [1] IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
279 Th17 cell differentiation 💬
 [4] RARA, RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
280 Thyroid cancer 💬
 [3] RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
281 Thyroid hormone signaling pathway 💬
 [3] RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
282 TNF signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
283 TNF signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
284 TNF signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
285 Toll-like receptor signaling pathway 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
286 Toll-like receptor signaling pathway 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
287 Toll-like receptor signaling pathway 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
288 Toll-like receptor signaling pathway 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
289 Toxoplasmosis 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
290 Toxoplasmosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
291 Toxoplasmosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
292 Toxoplasmosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
293 Transcriptional misregulation in cancer 💬
 [1] IL1R2 💬 D02934 💬 Anakinra [19]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
294 Transcriptional misregulation in cancer 💬
 [4] RARA, RXRA, RXRB, RXRG 💬 D02754 💬 Acitretin [1] 37 💬
295 Tuberculosis 💬
 [3] IL12A, IL12B, IL23A 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
296 Tuberculosis 💬
 [1] IL23A 💬 D10438 💬 Guselkumab [4] 37, 41, 96, 97 💬
297 Tuberculosis 💬
 [1] IL23A 💬 D11123 💬 Mirikizumab [3] 37, 96, 97 💬
298 Tuberculosis 💬
 [1] IL23A 💬 D11052 💬 Risankizumab [4] 37, 96, 97, 271 💬
299 Tuberculosis 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
300 Tuberculosis 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
301 Tuberculosis 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
302 Tuberculosis 💬
 [1] VDR 💬 D00129 💬 Calcitriol [8] 37, 46, 49, 66, 96, 158, 235, 326 💬
303 Type I diabetes mellitus 💬
 [2] IL12A, IL12B 💬 D09214 💬 Ustekinumab [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
304 Type I diabetes mellitus 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
305 Type I diabetes mellitus 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
306 Type I diabetes mellitus 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
307 Type II diabetes mellitus 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
308 Type II diabetes mellitus 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
309 Type II diabetes mellitus 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
310 Viral myocarditis 💬
 [1] ITGAL 💬 D03959 💬 Efalizumab [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
311 Viral protein interaction with cytokine and cytokine receptor 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
312 Viral protein interaction with cytokine and cytokine receptor 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
313 Viral protein interaction with cytokine and cytokine receptor 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
314 Yersinia infection 💬
 [1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
315 Yersinia infection 💬
 [1] TNF 💬 D03441 💬 Certolizumab pegol [6] 37, 46, 96, 97, 226, 271 💬
316 Yersinia infection 💬
 [1] TNF 💬 D02598 💬 Infliximab [25] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬

Back to top